| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-29 13:28:26 -0600 |
| HMDB ID |
HMDB00679 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Homocitrulline |
| Description |
Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970 ). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- Homo-L-citrulline
- Homocitrulline
- L-Homocitrulline
- N-e-Carbamyl-L-lysine
- N-epsilon-Carbamyl-L-lysine
- N6-carbamoyl-L-Lysine
- N6-carbamoyl-Lysine
|
| Chemical Formula |
C7H15N3O3 |
| Average Molecular Weight |
189.2123 |
| Monoisotopic Molecular Weight |
189.111341361 |
| IUPAC Name |
(2S)-2-amino-6-(carbamoylamino)hexanoic acid |
| Traditional IUPAC Name |
L-homocitrulline |
| CAS Registry Number |
1190-49-4 |
| SMILES |
N[C@@H](CCCCNC(N)=O)C(O)=O |
| InChI Identifier |
InChI=1S/C7H15N3O3/c8-5(6(11)12)3-1-2-4-10-7(9)13/h5H,1-4,8H2,(H,11,12)(H3,9,10,13)/t5-/m0/s1 |
| InChI Key |
XIGSAGMEBXLVJJ-YFKPBYRVSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Amino Fatty Acids
- Organic Compounds
- Straight Chain Fatty Acids
- amino acid zwitterion(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Polyamine
- Primary Aliphatic Amine (Alkylamine)
- Urea
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Protein synthesis, amino acid biosynthesis
|
| Application |
Not Available
|
| Cellular locations |
- Cytoplasm (predicted from logP)
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
211 - 212 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
600 mg/mL |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm (predicted from logP)
|
| Biofluid Locations |
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
5.0 (0.0-12.0) uM |
Newborn (0-30 days old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
6.0 (0-8.8) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
7.5 (3.8-13.8) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022178 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
58582  |
| KEGG Compound ID |
C02427  |
| BioCyc ID |
CPD-161  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB00679  |
| Metagene Link |
HMDB00679  |
| METLIN ID |
46  |
| PubChem Compound |
65072  |
| PDB ID |
Not Available |
| ChEBI ID |
17443  |
| References |
| Synthesis Reference |
Stark, George R. Reactions of cyanate with functional groups of proteins. III. Reactions with amino and carboxyl groups. Biochemistry (1965), 4(6), 1030-6. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Kato T, Sano M, Mizutani N: Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur J Pediatr. 1987 Jan;146(1):56-8.
Pubmed: 3107993
- Tuchman M, Knopman DS, Shih VE: Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome. Arch Neurol. 1990 Oct;47(10):1134-7.
Pubmed: 2222247
- Rajantie J, Simell O, Perheentupa J: Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance. J Pediatr. 1983 Mar;102(3):388-90.
Pubmed: 6402575
- Dionisi Vici C, Bachmann C, Gambarara M, Colombo JP, Sabetta G: Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement. Pediatr Res. 1987 Sep;22(3):364-7.
Pubmed: 3116497
- Hommes FA, Roesel RA, Metoki K, Hartlage PL, Dyken PR: Studies on a case of HHH-syndrome (hyperammonemia, hyperornithinemia, homocitrullinuria). Neuropediatrics. 1986 Feb;17(1):48-52.
Pubmed: 3960284
- Koshiishi I, Kobori Y, Imanari T: Determination of citrulline and homocitrulline by high-performance liquid chromatography with post-column derivatization. J Chromatogr. 1990 Oct 26;532(1):37-43.
Pubmed: 2079537
- Evered DF, Vadgama JV: Absorption of homocitrulline from the gastrointestinal tract. Br J Nutr. 1983 Jan;49(1):35-42.
Pubmed: 6821687
- Kato T, Sano M, Mizutani N, Hayakawa C: Homocitrullinuria and homoargininuria in hyperargininaemia. J Inherit Metab Dis. 1988;11(3):261-5.
Pubmed: 2466169
- Kato T, Sano M: Effect of ammonium chloride on homocitrulline and homoarginine synthesis from lysine. J Inherit Metab Dis. 1993;16(5):906-7.
Pubmed: 7507534
- Kato T, Sano M, Mizutani N: Homocitrullinuria and homoargininuria in lysinuric protein intolerance. J Inherit Metab Dis. 1989;12(2):157-61.
Pubmed: 2474087
- Zammarchi E, Donati MA, Filippi L, Resti M: Cryptogenic hepatitis masking the diagnosis of ornithine transcarbamylase deficiency. J Pediatr Gastroenterol Nutr. 1996 May;22(4):380-3.
Pubmed: 8732901
- Simell O, Mackenzie S, Clow CL, Scriver CR: Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Pediatr Res. 1985 Dec;19(12):1283-7.
Pubmed: 4080446
- Kraus LM, Gaber L, Handorf CR, Marti HP, Kraus AP Jr: Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage. Swiss Med Wkly. 2001 Mar 24;131(11-12):139-4.
Pubmed: 11416886
- Kraus LM, Elberger AJ, Handorf CR, Pabst MJ, Kraus AP Jr: Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis. J Lab Clin Med. 1994 Jun;123(6):882-91.
Pubmed: 8201267
|